Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
The versatile world of inflammatory chemokines in cancer
Tal Leibovich-Rivkin
, Yaeli Lebel-Haziv
, Shalom Lerrer
, Polina Weitzenfeld
,
Adit Ben-Baruch
*
*
Corresponding author for this work
Department of Cell Research and Immunology
Tel Aviv University
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The versatile world of inflammatory chemokines in cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
In Cancer
100%
Chemokines
100%
Inflammatory Chemokines
100%
Malignancy
50%
Tumor Cells
33%
Tumor-promoting
33%
CXCR3
33%
ELR-CXC Chemokines
33%
Chemokine Ligands
33%
Inflammation
16%
Role in Cancer
16%
Cytotoxic T Lymphocytes
16%
Interleukin-8
16%
Therapeutic Target
16%
Immune Suppression
16%
Double-edged Sword
16%
Angiogenesis
16%
Proliferation Migration
16%
Metastasis
16%
Tumor Microenvironment
16%
Tumor Site
16%
Gatekeepers
16%
CXCL8
16%
C-C Chemokine Receptor Type 5 (CCR5)
16%
CXCL10
16%
Osteoclastogenesis
16%
Th1 Cells
16%
Primary Tumor Site
16%
CCL5
16%
CXCL1
16%
Tumor-associated Macrophages
16%
Chemokine (C-C motif) Ligand 2 (CCL2)
16%
CCR2
16%
Monocyte Chemoattractant protein-1 (MCP-1)
16%
CCL3
16%
Receptor-based
16%
Regulatory T (Treg) Cells
16%
Metastatic Site
16%
Promoting Role
16%
RANTES
16%
CXCL9
16%
CXCL11
16%
Malignancy Phenotype
16%
CXCR2
16%
CXCR1
16%
Myeloid-derived Suppressor Cells
16%
MIP-1b
16%
ENA-78
16%
Immune Imbalance
16%
CXCL5
16%
Expected Difficulty
16%
Immunology and Microbiology
Chemokine
100%
Tumor Cell
16%
CXCR3
16%
Alpha Chemokine
16%
Regulatory T Cell
8%
Angiogenesis
8%
Cytotoxic T Cell
8%
CCR5
8%
Osteoclastogenesis
8%
CCL2
8%
CCR2
8%
CCL5
8%
Tumor-Associated Macrophage
8%
RANTES
8%
CXCL10
8%
CXCL11
8%
CXCL9
8%
Myeloid-Derived Suppressor Cell
8%
Epithelial Derived Neutrophil Activating Factor 78
8%
Th1 Cell
8%
CXCL1
8%
CXCL5
8%
CCL3
8%
Melanoma Growth Stimulatory Activity Factor
8%
Interleukin 8
8%